World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 12 February 2013
Main ID:  ISRCTN54378178
Date of registration: 20/12/2005
Primary sponsor: University Medical Centre Utrecht (UMCU) (Netherlands)
Public title: Asthma: a disease due to a lack of bacterial infections in childhood INDIAAN
Scientific title:
Date of first enrolment: Jan 1 1999
Target sample size: 120
Recruitment status: Completed/Not recruiting
URL:  http://isrctn.org/ISRCTN54378178
Study type:  Interventional
Study design:  Randomised, single blind, placebo controlled, parallel group trial  
Countries of recruitment
Netherlands
Contacts
Name: M O  Hoekstra
Address:  University Medical Centre Utrecht Wilhelmina Children's Hospital P.O. Box 85090 3508 AB Utrecht Netherlands
Telephone: +31 (0)30 250 4001
Email: m.o.hoekstra@umcutrecht.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: High-risk newborns. High-risk was defined as either a mother or a father plus a sibling with present or past atopic disease.
Exclusion criteria: 1. Maternal infection in the last week of pregnancy
2. The use of immunomodulatory drugs or antibiotics during pregnancy (mother)
3. The use of antibiotics prenatally (mother and newborn)
4. Prematurity
5. Signs of intra-uterine infection
6. Premature rupture of membranes
7. Presence of congenital disorders of the airways
8. Sever other congenital disorders
9. Need for mechanical ventilation
10. Prolonged administration of extra oxygen
11. Need for intensive care treatment


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Atopic disease, asthma
Intervention(s)
BCG vaccination or placebo.
Primary Outcome(s)
Incidence and severity of atopic disease at the age of 4 years.
Secondary Outcome(s)
1. SCORing Atopic Dermatitis (SCORAD)
2. Lung function
3. Cytokine production
4. Natural Resistance Associated Macrophage Protein (NRAMP) polymorphisms
Secondary ID(s)
NWO-NAF 3.2.93.96.2
Source(s) of Monetary Support
1. The Netherlands Organization for Scientific Research (NWO) (The Netherlands) 2. Netherlands Asthma Foundation (The Netherlands)
Secondary Sponsor(s)
N/A
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history